文献速递心脑血管急症

急诊胸痛患者应用HEART、GRACE和TIMI评分联合单次当代肌钙蛋白预测30天主要不良心脏事件的风险分层

Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events.
PubMed 文献 · Emerg Med J · 2018-04-05
一句话结论HEART评分≤3分联合单次当代肌钙蛋白对30天主要不良心脏事件敏感性99.5%、阴性预测值99.6%,达到安全离院策略阈值。

该前瞻性观察性队列研究在英国一家三级医院纳入疑似心脏性胸痛且初始心电图无显著ST段抬高的患者,于2014年12月2日至2016年2月8日收集数据,使用就诊时单次当代肌钙蛋白计算HEART、GRACE和TIMI评分,主要终点为30天主要不良心脏事件。1000例患者中189例发生30天主要不良心脏事件。HEART评分对30天主要不良心脏事件的C统计量为0.87(95%CI 0.84至0.90),高于TIMI的0.78(95%CI 0.74至0.81)和GRACE的0.74(95%CI 0.70至0.78)。HEART评分≤3分识别低危患者的敏感性为99.5%(95%CI 97.1%至99.9%),阴性预测值为99.6%(95%CI 97.3%至99.9%),均超过TIMI 0分和GRACE 0-55分。作者认为这些结果达到安全离院策略的阈值,但应结合其他研究审慎解读。

要点

  • HEART评分≤3分联合单次当代肌钙蛋白对30天主要不良心脏事件敏感性99.5%(95%CI 97.1%至99.9%),阴性预测值99.6%(95%CI 97.3%至99.9%)。
  • HEART评分对30天主要不良心脏事件的C统计量0.87(95%CI 0.84至0.90),高于TIMI的0.78(95%CI 0.74至0.81)和GRACE的0.74(95%CI 0.70至0.78)。
  • TIMI 0分敏感性97.4%(95%CI 93.9%至99.1%)、阴性预测值97.8%(95%CI 94.8%至99.1%),低于HEART评分≤3分。
  • GRACE 0-55分敏感性95.2%(95%CI 91.1%至97.8%)、阴性预测值95.8%(95%CI 92.2%至97.7%),低于HEART评分≤3分。
  • 1000例疑似心脏性胸痛且初始心电图无显著ST段抬高患者中,189例发生30天主要不良心脏事件。

适用人群与场景

  • 英国一家三级医院中疑似心脏性胸痛且初始心电图无显著ST段抬高的患者。

诊断标准与关键阈值

  • HEART评分≤3分定义为低危,联合就诊时单次当代肌钙蛋白计算。
  • TIMI 0分定义为低危。
  • GRACE评分0-55分定义为低危。

研究设计与关键结果

  • 前瞻性观察性队列研究,纳入1000例疑似心脏性胸痛且初始心电图无显著ST段抬高的患者,189例发生30天主要不良心脏事件。
  • HEART评分对30天主要不良心脏事件的C统计量0.87(95%CI 0.84至0.90),高于TIMI的0.78(95%CI 0.74至0.81)和GRACE的0.74(95%CI 0.70至0.78)。
  • HEART评分≤3分识别低危患者敏感性99.5%(95%CI 97.1%至99.9%)、阴性预测值99.6%(95%CI 97.3%至99.9%)。
  • TIMI 0分敏感性97.4%(95%CI 93.9%至99.1%)、阴性预测值97.8%(95%CI 94.8%至99.1%)。
  • GRACE评分0-55分敏感性95.2%(95%CI 91.1%至97.8%)、阴性预测值95.8%(95%CI 92.2%至97.7%)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,使用就诊时单次当代肌钙蛋白计算的HEART评分≤3分对30天主要不良心脏事件的敏感性和阴性预测值均≥99.5%,达到安全离院策略的阈值,但应结合其他研究审慎解读。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The majority of patients presenting to the ED with cardiac sounding chest pain have a non-diagnostic ECG and the problem of differentiating those suffering an acute coronary syndrome from those without is familiar to all ED clinical staff. To stratify risk in these patients, specific scores have been developed. Recent work has focused on incorporating newer high-sensitivity cardiac troponin (hs-cTn) assays; however, issues regarding performance and availability of these assays remain.

AIM: Prospectively compare HEART, Global Registry of Acute Coronary Events (GRACE) and Thrombolysis in Myocardial Infarction (TIMI) scores, using a single contemporary cTn at admission, to predict a major adverse cardiac event (MACE) at 30 days.

METHOD: Prospective observational cohort study performed in a UK tertiary hospital in patients with suspected cardiac chest pain and no significant ST elevation on initial ECG. Data collection took place 2 December 2014 to 8 February 2016. The treating clinician recorded risk score data real time and a single contemporary cTn taken at presentation was used in score calculation. The primary endpoint was 30-day MACE. C-statistic was determined for each score and diagnostic characteristics of high-risk and low-risk cut-offs were calculated.

RESULTS: 189/1000 patients in the study developed a 30-day MACE. The c-statistic of HEART for 30-day MACE (0.87 (95% CI 0.84 to 0.90)) was higher than TIMI (0.78 (95% CI 0.74 to 0.81)) and GRACE (0.74 (95% CI 0.70 to 0.78)).HEART score ≤3 identified low-risk patients with sensitivity 99.5% (95% CI 97.1% to 99.9%) and negative predictive value (NPV) 99.6% (95% CI 97.3% to 99.9%) exceeding TIMI 0 (sensitivity 97.4% (95% CI 93.9% to 99.1%) and NPV 97.8% (95% CI 94.8% to 99.1%)) and GRACE score 0-55 (sensitivity 95.2% (95% CI 91.1% to 97.8%) and NPV 95.8% (95% CI 92.2% to 97.7%)).

CONCLUSION: HEART outperformed both TIMI and GRACE in overall discriminative capacity for 30-day MACE. Using a single contemporary cTn at presentation, a HEART score of ≤3 demonstrated sensitivity and NPV of ≥99.5% for 30-day MACE. These results reach the threshold for a safe discharge strategy but should be interpreted thoughtfully in light of other work.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Reaney PDW, Elliott HI, Noman A, et al. Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events. Emerg Med J. 2018. PMID: 29622596. doi:10.1136/emermed-2017-207172

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。